Insmed
INSM
#959
Rank
NZ$45.22 B
Marketcap
NZ$206.16
Share price
1.48%
Change (1 day)
-39.55%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -NZ$0.91 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$1.51 Billion. In 2025 the company made an earning of -NZ$2.13 Billion a decrease over its 2024 earnings that were of -NZ$1.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.91 Billion-57.23%
2025 -NZ$2.13 Billion43.91%
2024 -NZ$1.48 Billion23.71%
2023 -NZ$1.2 Billion45.77%
2022 -NZ$0.82 Billion15.83%
2021 -NZ$0.71 Billion50.19%
2020 -NZ$0.47 Billion16.4%
2019 -NZ$0.41 Billion-23.9%
2018 -NZ$0.54 Billion59.35%
2017 -NZ$0.34 Billion8.52%
2016 -NZ$0.31 Billion47.25%
2015 -NZ$0.21 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$97.46 Million35.14%
2012 -NZ$72.12 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$11.1 Million-105.22%
2009 NZ$0.21 B-905.06%
2008 -NZ$26.39 Million-27.31%
2007 -NZ$36.3 Million-62.41%
2006 -NZ$96.55 Million98.19%
2005 -NZ$48.72 Million0.03%
2004 -NZ$48.7 Million159.07%
2003 -NZ$18.8 Million-69.31%
2002 -NZ$61.25 Million
2000 -NZ$55.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$22.45 B-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-NZ$3.48 Billion 274.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.95 B-1,065.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$41.27 Million-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$91.72 Million-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA